Researchers at the Texas A&M Health Institute of Biosciences and Technology have developed a tool using a simple light to manipulate proteins and microtubules in the cells of the body, giving researchers new ways to observe progression and implications of complex diseases like cancer and dementia.

The study, published in Cell Reports Methods, was led by Yubin Zhou, MD, PhD, FAAAS, FAIMBE, FRSC, director of the Center for Translational Cancer Research at the Institute of Biosciences and Technology and professor in the Texas A&M Naresh K. Vashisht College of Medicine, together with Yun Huang, PhD, FRSC, professor and associate director of the Center for Epigenetics and Disease Prevention.

A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.